Risk of severe rash in cancer patients treated with EGFR tyrosine kinase inhibitors: a systematic review and meta-analysis

Future Oncology Ahead of Print.


from Cancer via ola Kala on Inoreader http://ift.tt/2bumANo
via IFTTT